Biomarker-guided antifungal therapy in patients with suspected invasive candidiasis: Ready for prime time?

被引：4
作者：
Paiva, Jose-Artur [1 ,2 ]
Charles, Pierre-Emmanuel [3 ]
机构：
[1] Univ Porto, Ctr Hosp Sao Joao, Dept Emergency & Intens Care, Fac Med, Oporto, Portugal
[2] Grp Infecao & Sepsis, Oporto, Portugal
[3] CHU Dijon, Serv Med Intens Reanimat, Hop Francois Mitterrand, Dijon, France
来源：
INTENSIVE CARE MEDICINE | 2017年 / 43卷 / 12期
关键词：
CRITICALLY-ILL PATIENTS; INFECTION; DISCONTINUATION; OUTCOMES; ADULTS;
D O I：
10.1007/s00134-017-4990-y
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1889 / 1891
页数：3
相关论文
共 17 条
  • [1] Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data
    Bailly, Sebastien
    Leroy, Olivier
    Montravers, Philippe
    Constantin, Jean-Michel
    Dupont, Herve
    Guillemot, Didier
    Lortholary, Olivier
    Mira, Jean-Paul
    Perrigault, Pierre-Francois
    Gangneux, Jean-Pierre
    Azoulay, Elie
    Timsit, Jean-Francois
    [J]. INTENSIVE CARE MEDICINE, 2015, 41 (11) : 1931 - 1940
  • [2] Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study
    Bassetti, Matteo
    Peghin, Maddalena
    Carnelutti, Alessia
    Righi, Elda
    Merelli, Maria
    Ansaldi, Filippo
    Trucchi, Cecilia
    Alicino, Cristiano
    Sartor, Assunta
    Toniutto, Pierluigi
    Wauters, Joost
    Laleman, Wim
    Tascini, Carlo
    Menichetti, Francesco
    Luzzati, Roberto
    Brugnaro, Pierluigi
    Mesini, Alessio
    Raviolo, Stefania
    De Rosa, Francesco G.
    Lagunes, Leonel
    Rello, Jordi
    Dimopoulos, George
    Colombo, Arnaldo L.
    Nucci, Marcio
    Vena, Antonio
    Bouza, Emilio
    Munoz, Patricia
    Tumbarello, Mario
    Losito, Raffaella
    Martin-Loeches, Ignacio
    Viscoli, Claudio
    [J]. INTENSIVE CARE MEDICINE, 2017, 43 (04) : 509 - 518
  • [3] Serum procalcitonin for the early recognition of nosocomial infection in the critically ill patients: a preliminary report
    Charles, Pierre Emmanuel
    Kus, Emmanuel
    Aho, Serge
    Prin, Sebastien
    Doise, Jean-Marc
    Olsson, Nils-Olivier
    Blettery, Bernard
    Quenot, Jean-Pierre
    [J]. BMC INFECTIOUS DISEASES, 2009, 9
  • [4] Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial
    de Jong, Evelien
    van Oers, Jos A.
    Beishuizen, Albertus
    Vos, Piet
    Vermeijden, Wytze J.
    Haas, Lenneke E.
    Loef, Bert G.
    Dormans, Tom
    van Melsen, Gertrude C.
    Kluiters, Yvette C.
    Kemperman, Hans
    van den Elsen, Maarten J.
    Schouten, Jeroen A.
    Streefkerk, Joern O.
    Krabbe, Hans G.
    Kieft, Hans
    Kluge, Georg H.
    van Dam, Veerle C.
    van Pelt, Joost
    Bormans, Laura
    Otten, Martine Bokelman
    Reidinga, Auke C.
    Endeman, Henrik
    Twisk, Jos W.
    van de Garde, Ewoudt M. W.
    de Smet, Anne Marie G. A.
    Kesecioglu, Jozef
    Girbes, Armand R.
    Nijsten, Maarten W.
    de lange, Dylan W.
    [J]. LANCET INFECTIOUS DISEASES, 2016, 16 (07) : 819 - 827
  • [5] Outcomes associated with routine systemic antifungal therapy in critically ill patients with Candida colonization
    Ferreira, David
    Grenouillet, Frederic
    Blasco, Gilles
    Samain, Emmanuel
    Henon, Thierry
    Dussaucy, Alain
    Millon, Laurence
    Mercier, Mariette
    Pili-Floury, Sebastien
    [J]. INTENSIVE CARE MEDICINE, 2015, 41 (06) : 1077 - 1088
  • [6] Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study
    Jensen, R. H.
    Johansen, H. K.
    Soes, L. M.
    Lemming, L. E.
    Rosenvinge, F. S.
    Nielsen, L.
    Olesen, B.
    Kristensen, L.
    Dzajic, E.
    Astvad, K. M. T.
    Arendrup, M. C.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (03) : 1500 - 1508
  • [7] Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
    Kollef, Marin
    Micek, Scott
    Hampton, Nicholas
    Doherty, Joshua A.
    Kumar, Anand
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (12) : 1739 - 1746
  • [8] Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
    Leroy, Olivier
    Bailly, Sebastien
    Gangneux, Jean-Pierre
    Mira, Jean-Paul
    Devos, Patrick
    Dupont, Herve
    Montravers, Philippe
    Perrigault, Pierre-Francois
    Constantin, Jean-Michel
    Guillemot, Didier
    Azoulay, Elie
    Lortholary, Olivier
    Bensoussan, Caroline
    Timsit, Jean-Francois
    [J]. ANNALS OF INTENSIVE CARE, 2016, 6 : 1 - 11
  • [9] Discontinuation of empirical antifungal therapy in ICU patients using 1,3-β-D-glucan
    Nucci, Marcio
    Nouer, Simone A.
    Esteves, Patricia
    Guimaraes, Thais
    Breda, Giovanni
    de Miranda, Bianca Grassi
    Queiroz-Telles, Flavio
    Colombo, Arnaldo L.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (09) : 2628 - 2633
  • [10] MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting
    Ostrosky-Zeichner, Luis
    Shoham, Shmuel
    Vazquez, Jose
    Reboli, Annette
    Betts, Robert
    Barron, Michelle A.
    Schuster, Mindy
    Judson, Marc A.
    Revankar, Sanjay G.
    Caeiro, Juan Pablo
    Mangino, Julie E.
    Mushatt, David
    Bedimo, Roger
    Freifeld, Alison
    Minh Hong Nguyen
    Kauffman, Carol A.
    Dismukes, William E.
    Westfall, Andrew O.
    Deerman, Jeanna Beth
    Wood, Craig
    Sobel, Jack D.
    Pappas, Peter G.
    [J]. CLINICAL INFECTIOUS DISEASES, 2014, 58 (09) : 1219 - 1226
12